Viewing Study NCT02220712


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2026-03-03 @ 12:52 AM
Study NCT ID: NCT02220712
Status: COMPLETED
Last Update Posted: 2021-01-25
First Post: 2014-08-18
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multicenter Open-label Study Investigating the Pharmacokinetics and Safety of Aripiprazole IM Depot Formulation (OPC-14597 IMD) During Repeated Administration by Injection Into the Deltoid Muscle in Patients With Schizophrenia
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 031-13-005
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators